Developing vaccines for cancer is more challenging because cancer cells look more like our normal, healthy cells, making it ...

SCG Cell Therapy Pte Ltd (SCG), announced the signing of a Memorandum of Understanding (MoU) with A*STAR BTI and NATi to ...

The study, conducted by a group of healthcare experts, highlighted the need for increased awareness and access to booster ...

A study focusing on what countries must do to reduce the cost of therapeutic drugs and making protein vaccines by a Ugandan ...

The US Food and Drug Administration (FDA) has put on hold all respiratory syncytial virus (RSV) vaccine trials involving infants (aged under 2 years) or RSV naive children aged 2-5 years, after a ...

One Facebook post is captioned: “Turbo Cancer is spreading like wildfire, threatening to kill BILLIONS globally in just 2 ...

This year has been marked by concerning developments in the virus’ spread, including widespread detections in wastewater and ...

Public Employees Retirement System of Ohio purchased a new stake in CureVac (NASDAQ:CVAC – Free Report) in the third quarter, ...

Shocking Data Reveals COVID Vaccinated Face Alarming Death Surge** Emerging data from the UK government has raised serious concerns about the safety of COVID-19 vaccinations. Re ...

Respiratory syncytial virus (RSV) is a major cause of respiratory infections, particularly in infants, children under 5 years, and older adults. Its rapid spread makes RSV a serious public health ...

What do you make of 2024? If you ask most people in what you might describe as the political class, the answer would be negative. And to some extent, you might see their point.

XTX Topco Ltd lessened its position in CureVac (NASDAQ:CVAC – Free Report) by 59.5% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange ...